Table 3.
Anti-psychotics | Anxiolytics, hypnotics, and sedatives | Attention-deficit/hyperactivity disorder medication | Drugs used in addictive disorders | Opioids | Anti-epileptics | |
---|---|---|---|---|---|---|
Children (0–11 years) | ||||||
User (N = 833) | 158 (19.0%) | 415 (49.8%) | 397 (47.7%) | 1 (0.1%) | 14 (1.7%) | 50 (6.0%) |
Control (N = 833) | 4 (0.5%) | 13 (1.6%) | 25 (3.0%) | 0 (0.0%) | 0 (0.0%) | 5 (0.6%) |
OR (95% CI)a | 52.0 (18.8, 142.7) | 64.1 (36.4, 112.7) | 31.6 (20.7, 48.4) | – | – | 10.7 (4.2, 27.0) |
Adolescents (12–17 years) | ||||||
User (N = 10,033) | 1300 (13.0%) | 5725 (57.1%) | 2756 (27.5%) | 33 (0.3%) | 486 (4.8%) | 531 (5.3%) |
Control (N = 10,033) | 23 (0.2%) | 195 (1.9%) | 271 (2.7%) | 2 (0.0%) | 124 (1.2%) | 51 (0.5%) |
OR (95% CI)a | 65.2 (43.1, 98.6) | 68.0 (58.6, 78.7) | 14.4 (12.6, 16.4) | 16.6 (4.0, 69.0) | 4.1 (3.4, 5.0) | 11.0 (8.2, 14.6) |
Young adults (18–24 years) | ||||||
User (N = 47,988) | 6337 (13.2%) | 25,848 (53.9%) | 5219 (10.9%) | 947 (2.0%) | 6050 (12.6%) | 5258 (11.0%) |
Control (N = 47,988) | 192 (0.4%) | 1233 (2.6%) | 550 (1.1%) | 45 (0.1%) | 1642 (3.4%) | 414 (0.9%) |
OR (95% CI)a | 38.1 (33.0, 44.0) | 44.4 (41.8, 47.1) | 10.7 (9.8, 11.7) | 21.5 (15.9, 29.0) | 4.1 (3.9, 4.3) | 14.2 (12.8, 15.7) |
aAdjusted for sex and age (in 1-year bands)